Signaling pathways in renal cell carcinoma
摘要：
Renal cell carcinoma (RCC), the most lethal type of genitourinary cancer, is generally resistant to chemotherapy and radiation therapy. Surgical excision of the tumor at a localized stage remains the mainstay for curative therapy. A number of drugs developed in recent years have shown limited to significant efficacy in treating RCC. These drugs act by blocking critical signaling pathways associated with RCC tumor growth and survival, and angiogenesis. Beyond well-validated signaling targets such as VHL, VEGFR and mTOR, additional pathways including HGF/c-MET and Wnt/β-catenin have emerged as important to RCC pathogenesis. Mutations in one or more components of these signaling networks may affect tumor response to therapy. This review summarizes the state of knowledge about signaling pathways in RCC and discusses the known genetic and epigenetic alterations that underlie dysregulation of these pathways.
展开
DOI：
10.4161/cbt.10.7.13247
被引量：
年份：
2010
Taylor & Francis
国家科技图书文献中心
(权威机构)
万方
Semantic Scholar
掌桥科研
查看更多
dx.doi.org
Europe PMC
NCBI
NCBI
Oxford Univ Press
ResearchGate
(全网免费下载)
ResearchGate
landesbioscience.com
钛学术
mct.aacrjournals.org
jco.ascopubs.org
pubget.com
mendeley.com
eurekah.com
insectscience.org
rsob.royalsocietypublishing.org
pubfacts.com
science-open.com
onAcademic
钛学术
(全网免费下载)
ResearchGate
(全网免费下载)
钛学术
(全网免费下载)
通过文献互助平台发起求助，成功后即可免费获取论文全文。
相似文献
参考文献
引证文献
来源期刊
引用走势
辅助模式
引用
文献可以批量引用啦~
欢迎点我试用！
